Zeuthen, Germany

Cornelius Frommel

This inventor holds 1 USPTO granted patent. Top assignee: Institut Fue Diagnostikforschung Gmbh. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cornelius Frommel. Retrieved from https://idiyas.com/inventor/cornelius-frommel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Cornelius Frommel and Targeted Diagnostic Peptides.

Introduction

Cornelius Frommel is an inventor associated with Zeuthen, Germany, and Institut für Diagnostikforschung GmbH. His work includes a patented approach to metal-binding, cysteine-free peptides designed for diagnostic and therapeutic applications.

Latest Patents

Frommel is associated with 1 patent: “Metal-binding cystein-free peptides for diagnostic and therapeutical purposes, methods for their production, and pharmaceuticals containing these compounds.” The invention describes peptides that bind metals and can be linked to organ-specific probes, such as antibodies or antibody fragments targeting tumor-associated antigens. These conjugates are intended to accumulate selectively in tumors, organs, tissues, or sites of inflammation.

The patent also covers methods for producing the peptides and their conjugates, as well as their use in kits for in vivo diagnosis or therapy. Radioisotope-containing radiopharmaceuticals based on the conjugates are described for imaging or treating tumors, organs, and inflammatory sites.

Career Highlights

The patent reflects Frommel’s involvement in research connecting peptide chemistry with targeted medical imaging and therapy. The described technology aims to direct diagnostic or therapeutic compounds toward specific biological targets.

Collaborations

Frommel’s listed coworkers include Ludger Dinkelborg and Gabriele Kuttner. The patent describes work involving organ-specific probes and peptide conjugates, although the supplied information does not specify the individual contributions of these collaborators.

Conclusion

Cornelius Frommel’s patent focuses on metal-binding, cysteine-free peptides that can be paired with targeted probes for diagnostic imaging and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…